JP2006514627A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006514627A5 JP2006514627A5 JP2004552884A JP2004552884A JP2006514627A5 JP 2006514627 A5 JP2006514627 A5 JP 2006514627A5 JP 2004552884 A JP2004552884 A JP 2004552884A JP 2004552884 A JP2004552884 A JP 2004552884A JP 2006514627 A5 JP2006514627 A5 JP 2006514627A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- hapten
- enzyme
- target
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42637902P | 2002-11-15 | 2002-11-15 | |
| PCT/GB2003/004994 WO2004045642A1 (en) | 2002-11-15 | 2003-11-17 | Use of multi-specific, non-covalent complexes for targeted delivery of therapeutics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006514627A JP2006514627A (ja) | 2006-05-11 |
| JP2006514627A5 true JP2006514627A5 (cg-RX-API-DMAC10.html) | 2006-09-28 |
Family
ID=32326341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004552884A Pending JP2006514627A (ja) | 2002-11-15 | 2003-11-17 | 治療薬の標的化送達のための多重特異的非共有結合複合体の使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20040166115A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1560596A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2006514627A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2003283599C1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2505717A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2004045642A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7591994B2 (en) | 2002-12-13 | 2009-09-22 | Immunomedics, Inc. | Camptothecin-binding moiety conjugates |
| CA2531118C (en) * | 2003-07-01 | 2013-01-08 | Immunomedics, Inc. | Multivalent carriers of bi-specific antibodies |
| US20050261170A1 (en) * | 2004-01-22 | 2005-11-24 | Immunomedics, Inc. | Folate conjugates and complexes |
| US20060057062A1 (en) * | 2004-09-10 | 2006-03-16 | Trotter Dinko G | Compositions and methods useful in pretargeted imaging |
| CN101171034B (zh) | 2005-03-03 | 2014-06-18 | 免疫医疗公司 | 人源化l243抗体 |
| PL3912643T3 (pl) | 2009-02-13 | 2023-01-23 | Immunomedics Inc. | Immunokoniugaty z połączeniem rozszczepialnym wewnątrzkomórkowo |
| US9050375B2 (en) | 2009-07-06 | 2015-06-09 | Hoffmann-La Roche, Inc. | Bi-specific digoxigenin binding antibodies |
| LT2544719T (lt) | 2010-03-12 | 2019-10-25 | Debiopharm Int Sa | Cd37 surišančios molekulės, ir jų imunokonjugatai |
| AU2012236210B2 (en) | 2011-04-01 | 2016-02-04 | Immunogen, Inc. | CD37-binding molecules and immunoconjugates thereof |
| SG11201407420RA (en) | 2012-07-04 | 2015-02-27 | Hoffmann La Roche | Covalently linked antigen-antibody conjugates |
| EP2869837B1 (en) | 2012-07-04 | 2016-09-14 | F. Hoffmann-La Roche AG | Anti-theophylline antibodies and methods of use |
| MX354303B (es) | 2012-07-04 | 2018-02-23 | Hoffmann La Roche | Anticuerpos de anti-biotina y metodos de uso. |
| CR20160270A (es) | 2013-12-20 | 2016-09-05 | Hoffmann La Roche | ANTICUERPOS ANTI-TAU (pS422) HUMANIZADOS Y MÉTODOS DE UTILIZACIÓN |
| WO2015101586A1 (en) | 2014-01-03 | 2015-07-09 | F. Hoffmann-La Roche Ag | Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles |
| BR112016014945A2 (pt) | 2014-01-03 | 2018-01-23 | F. Hoffmann-La Roche Ag | conjugado, formulação farmacêutica e uso |
| EP3089758B1 (en) | 2014-01-03 | 2021-01-27 | F.Hoffmann-La Roche Ag | Covalently linked helicar-anti-helicar antibody conjugates and uses thereof |
| EP3129065B1 (en) | 2014-03-12 | 2026-05-13 | Akamara Therapeutics, Inc. | Targeted drug delivery through affinity based linkers |
| AR100978A1 (es) * | 2014-06-26 | 2016-11-16 | Hoffmann La Roche | LANZADERAS CEREBRALES DE ANTICUERPO HUMANIZADO ANTI-Tau(pS422) Y USOS DE LAS MISMAS |
| BR112017026027A2 (pt) | 2015-06-08 | 2018-08-14 | Debiopharm Int Sa | combinações de imunoconjugado anti-cd37 e anticorpo anti-cd20 |
| ES2809728T3 (es) | 2015-06-24 | 2021-03-05 | Hoffmann La Roche | Anticuerpos anti-tau(pS422) humanizados y procedimientos de uso |
| JP6890581B2 (ja) | 2015-08-28 | 2021-06-18 | デビオファーム インターナショナル, エス. アー. | Cd37の検出のための抗体およびアッセイ |
| US11278629B2 (en) | 2016-11-02 | 2022-03-22 | Debiopharm International, S.A. | Methods for improving anti-CD37 immunoconjugate therapy |
| AU2019277836A1 (en) | 2018-05-30 | 2021-01-21 | Debiopharm International, S.A. | Anti-CD37 immunoconjugate dosing regimens |
| EP4744681A1 (en) * | 2024-08-16 | 2026-05-20 | Shanghai Bao Pharmaceuticals Co., Ltd. | COMPLEX TARGETING TARGET CELLS AND ITS USE |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2604092B1 (fr) * | 1986-09-19 | 1990-04-13 | Immunotech Sa | Immunoreactifs destines a cibler les cellules animales pour leur visualisation ou leur destruction in vivo |
| US7074405B1 (en) * | 1998-06-22 | 2006-07-11 | Immunomedics, Inc. | Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| US6962702B2 (en) * | 1998-06-22 | 2005-11-08 | Immunomedics Inc. | Production and use of novel peptide-based agents for use with bi-specific antibodies |
| EP1113819B1 (en) * | 1998-09-18 | 2011-02-23 | Immunomedics, Inc. | Antibody directed enzyme prodrug therapy (adept) with glucuronidase |
-
2003
- 2003-11-17 AU AU2003283599A patent/AU2003283599C1/en not_active Ceased
- 2003-11-17 JP JP2004552884A patent/JP2006514627A/ja active Pending
- 2003-11-17 EP EP03775576A patent/EP1560596A1/en not_active Ceased
- 2003-11-17 US US10/714,391 patent/US20040166115A1/en not_active Abandoned
- 2003-11-17 WO PCT/GB2003/004994 patent/WO2004045642A1/en not_active Ceased
- 2003-11-17 CA CA002505717A patent/CA2505717A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN114456186B (zh) | 一种喜树碱类衍生物及其配体-药物偶联物 | |
| JP7458399B2 (ja) | 抗クローディン抗体及びそれらの使用 | |
| JP2006518737A5 (cg-RX-API-DMAC10.html) | ||
| JP5084267B2 (ja) | 多特異性抗体との使用のための治療および診断用コンジュゲート | |
| JP4625637B2 (ja) | 活性物質送達系及び活性物質を保護し投与する方法 | |
| JP2022113163A (ja) | 核酸キャリア及び治療上の使用方法 | |
| Meyer et al. | Site-specific prodrug activation by antibody-β-lactamase conjugates: Regression and long-term growth inhibition of human colon carcinoma xenograft models | |
| CN110545846A (zh) | 用于光免疫疗法的治疗组合物和相关方法 | |
| JP2009519931A5 (cg-RX-API-DMAC10.html) | ||
| AU2003283599C1 (en) | Use of multi-specific, non-covalent complexes for targeted delivery of therapeutics | |
| JP2006511526A (ja) | 細胞内で開裂可能な結合を有する免疫接合体 | |
| US20180271997A1 (en) | Methods and Reagents to Treat Tumor and Cancer | |
| CA2475395A1 (en) | Anti-human tenascin monoclonal antibody | |
| WO2018231661A1 (en) | Methods and reagents to treat tumor and cancer | |
| CN1946740B (zh) | 抗人腱生蛋白单克隆抗体 | |
| US7833528B2 (en) | Use of multispecific, non-covalent complexes for targeted delivery of therapeutics | |
| Hay et al. | Antibody-directed enzyme-prodrug therapy (ADEPT) | |
| US20060002940A1 (en) | Method of immunotherapy | |
| Koumarianou et al. | Development of a novel bi-specific monoclonal antibody approach for tumour targeting | |
| Yamaguchi et al. | Production, binding and cytotoxicity of human/mouse chimeric monoclonal antibody‐neocarzinostatin conjugate | |
| JP4616991B2 (ja) | 化学療法剤の標的特異的な毒性を増加させるための方法および組成物 | |
| EP4725508A1 (en) | Ligand-drug conjugate having free payload recovery unit | |
| WO2026098621A1 (zh) | 工程改造的定点偶联抗体、抗体偶联药物及其应用 | |
| CA3297994A1 (en) | Ligand-drug conjugate having free payload recovery unit | |
| Bajic | Treating colorectal cancer by targeting the carcinoembryonic antigen with immunocytokines and bispecific antibodies |